Background: Bleomycin pulmonary toxicity (BPT) has been described in Hodgkin's lymphoma (HL) patients treated with bleomycin-containing chemotherapy regimens.
Methodology: We reviewed the records of 164 consecutive HL patients.
Results: BPT was observed in 24 of 164 patients (15%).